Zixuan Zhao

Zixuan Zhao

Auto-generated profile, based on publicly available information

Zixuan Zhao

Key Laboratory of Environment and Disease‐Related Gene Ministry of Education/Department of Cell Biology and Genetics, School of Basic Medical Sciences Xi'an Jiaotong University Health Science Center Xi'an Shaanxi 710061 China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Scientia Horticulturae
Verified
Journal Article
Closed access
XZXuan Zhao
Xuan Zhao
Noor MuhammadNoor Muhammad
Noor Muhammad
ZZZixuan Zhao
Zixuan Zhao
KYKuilin Yin
Kuilin Yin
ZLZhiguo Liu
Zhiguo Liu
MLMengjun Liu
Mengjun Liu

4 May 2020 in Proteomics – Clinical Applications
Verified
Journal Article
Open access
PDF file
SZSiyuan Zhang
Siyuan Zhang
ZZZixuan Zhao
Zixuan Zhao
WDWenjing Duan
Wenjing Duan
ZLZhaoxin Li
Zhaoxin Li
ZNZhuhui Nan
Zhuhui Nan
CHchen huang
chen huang
Purpose: Mass spectrometry is one of the rapidly developing bio‐analytical techniques in recent years, and it shows that the results of biomarkers’ screening can be influenced by pre‐analytical process. The selection of the blood collection tubes is one of the most significant steps of pre‐analytical process which is often neglected by researchers. So, it is urgent to define the influence of blood collection tubes clearly in biomarkers’ screening.Experimental Design: Two types of blood collection tubes, non‐additive tubes and coagulant activator tubes, are used to collect serum samples from patients and healthy controls. All samples are analyzed using matrix‐assisted laser desorption ionization‐time of flight mass spectrum in this study.Results: The serum protein profile changes while using coagulant tubes whether for patients or healthy controls. It is found that the effect of coagulant on serum protein of patients is smaller than that of control group. There are 27 significantly different peaks between the control group and the control coagulant group. However, between patient group and patient coagulant group, only one differential peak is obtained. Coagulant changes the expression differences between patients and healthy controls, making the differences expand, shrink or reverse, and most of the polypeptides are small molecule, which will change the results of biomarker's screening.Conclusions and Clinical Relevance: This research suggested that different types of blood collection tubes would influence the final laboratory results. So it's important for clinicians to choose the proper tubes to detect biomarkers and make correct diagnoses.